What is the recommended treatment for a patient with bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bursitis

Start with conservative management including rest, ice application (10-minute periods through a wet towel), NSAIDs, and activity modification for 4-6 weeks before considering more invasive interventions. 1, 2

Initial Conservative Approach

The stepwise treatment algorithm prioritizes non-invasive measures first:

  • Rest and activity modification to eliminate pressure or repetitive motion on the affected bursa for 4-6 weeks 1, 2
  • Ice application for 10-minute periods through a wet towel for pain relief 1, 3, 2
  • NSAIDs as first-line pharmacologic therapy for pain and inflammation control 1, 3, 2, 4
    • For acute bursitis and tendonitis: naproxen 500 mg initially, then 500 mg every 12 hours or 250 mg every 6-8 hours (maximum 1250 mg first day, then 1000 mg daily thereafter) 4
  • Avoid complete immobilization to prevent muscular atrophy and deconditioning 3, 2

If NSAIDs are contraindicated or poorly tolerated, use paracetamol or opioids for pain control 1

Critical Diagnostic Step: Rule Out Septic Bursitis

Before any treatment, exclude septic bursitis—this requires completely different management with antibiotics rather than corticosteroids. 3, 2, 5

  • If infection is suspected: perform bursal aspiration with Gram stain, culture, cell count, glucose measurement, and crystal analysis 5
  • Septic bursitis requires antibiotics effective against Staphylococcus aureus (outpatient if not acutely ill; inpatient IV antibiotics if acutely ill) 5

Location-Specific Corticosteroid Injection Guidelines

After 4-6 weeks of failed conservative therapy, consider corticosteroid injection only for specific locations:

Safe for Injection:

  • Prepatellar bursitis: corticosteroid injection may be considered 1, 2
  • Olecranon bursitis: corticosteroid injection may be considered 1, 2
  • Trochanteric bursitis: ultrasound-guided bursal injection with lidocaine alone or combined with corticosteroid 1, 2, 6
    • Typical dose: 24 mg betamethasone with 1% lidocaine (or equivalent) 6

NEVER Inject Retrocalcaneal Bursitis:

  • Absolutely avoid corticosteroid injection in retrocalcaneal bursitis due to high risk of Achilles tendon rupture 1, 2
  • Instead, use immobilization with cast or fixed-ankle walker device 1, 2

Critical Pitfalls to Avoid

  • Never inject corticosteroids into a potentially infected bursa—this will worsen infection 2
  • Avoid routine aspiration of chronic microtraumatic bursitis—this creates risk of iatrogenic septic bursitis 2, 5
  • Do not use intra-articular hyaluronan if concurrent calcium pyrophosphate deposition disease is present—may trigger acute attacks 2

Surgical Intervention

Reserve surgery for recalcitrant cases after exhausting conservative measures:

  • Heel bursitis: resection of prominent posterior superior calcaneus and inflamed bursa 1, 2
  • Trochanteric bursitis: iliotibial band release, subgluteal bursectomy, or trochanteric reduction osteotomy for intractable symptoms 6
  • Refer to orthopedic surgery for surgical candidates or refractory cases 2

When to Suspect Systemic Disease

If multiple bursae are symptomatic simultaneously, consider systemic rheumatic disease and refer to rheumatology 1, 2

Prevention of Recurrence

Address modifiable risk factors to prevent recurrence:

  • Reduce repetitive motion and sustained pressure on affected areas 1, 2
  • Weight reduction if obese 1
  • For crystal-induced (gout-related) bursitis: reduce meat, seafood, and high-fructose foods; review diuretic use; limit alcohol intake 1, 2

References

Guideline

Management of Bursitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bursitis Management and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Olecranon Bursitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Common Superficial Bursitis.

American family physician, 2017

Research

Clinical inquiries. How should you treat trochanteric bursitis?

The Journal of family practice, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.